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Abstract
Background: Opioid overdose in Russia is a problem that has grown more severe as heroin abuse
expanded over the past decade, yet few studies have explored it in detail. In order to gain a clearer
understanding of the situation, 60 drug users, both in and out of drug treatment in St. Petersburg, were
interviewed concerning their overdose experience and knowledge about overdose recognition and
prevention.
Methods:  Using a semi-structured interview, we sought to identify and describe local attitudes,
knowledge and experience (both self-sustained and witnessed) of opioid overdose. Bi-variate and multiple
logistic regressions were performed in order to identify the relationship between overdose experience
and sociodemographic factors, risk behaviors, and clinical psychiatric measures.
Results: We found that having experienced or witnessed an opioid overdose within the previous year
was common, overdose knowledge was generally high, but nearly half the participants reported low self-
efficacy for effectively intervening in an overdose situation. In bivariate analyses, self-reported family
problems (i.e., perceived problematic family interactions) were positively associated with both
experiencing (t56 = 2.49; p < 0.05) and with witnessing a greater number of overdoses in the previous year
(rhos = 0.31; p < 0.05). Having previously overdosed [Adjusted Risk Ratio (ARR) 1.7, 95% Confidence
Interval (CI) 1.1–2.6] and higher SCL-90-R somatization scores (ARR 1.2, 95% CI 0.96 – 1.5) were
independently associated in multivariable analyses with self-sustained overdose experience in the past year.
Greater perceived likelihood of experiencing a future overdose and concern about medical problems were
independently associated with witnessing a higher number of overdoses within the previous year. Over
two thirds of the participants expressed interest in receiving training in overdose prevention and response.
Conclusion: Opioid overdose experience is very common among drug users in St. Petersburg, Russia,
and interest in receiving training for overdose recognition and prevention was high. Future research should
target the development of effective overdose recognition and prevention interventions, especially ones
that include naloxone distribution and involve drug users' families.
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Background
Since the 1990s, illegal drug use in the Russian Federation
has increased dramatically [1]. By 2005 there were over
500,000 registered drug users in Russia, with estimates for
the total number of drug users as high as six million for
that year http://www.fskn.gov.ru/fskn/index/
news.htm?id=10291318@cmsArticle. Opium production
in nearby Afghanistan provides many Russian cities with
an accessible and bountiful source of heroin, which is
administered primarily by injection [2-4]. Consequently,
injection-associated infections such as HIV and hepatitis
C virus are increasing among Russian drug users [5-7].
While the increases in injection-associated infections are
striking, the annual estimated mortality rate attributed to
drug overdose and problems related to drug use exceeds
100,000 [8] and surpasses mortality rates for HIV/AIDS
[5,7].
There are few published Russian epidemiologic studies of
opioid overdose. They tend to be regional studies and may
therefore lack specificity in local opioid overdose preva-
lence rates and associated risk factors [9,10]. One large,
multi-city study of drug users reported that more than
80% had ever witnessed an overdose of which 15% had
been fatal [10]. Overdose fatality rates among the general
population in Russia are increasing according to the State
Drug Control Committee which reported 70,000 drug-
related deaths in 2004 and 100,000 in 2005. Data from a
St. Petersburg study of 520 injectors reported an annual
overdose mortality rate of 2.1 per 100 person years [11] –
almost double the reported rates for some Western Euro-
pean countries [12,13] – yet overdose prevention cam-
paigns are rare. Building on the recognition of the large
impact of opioid overdoses in St. Petersburg, we sought to
identify and describe the contextual and psychosocial fac-
tors related to the outcome of experiencing and witness-
ing opioid overdose among a sample of 60 drug users.
Methods
Recruitment of Study Population
Inclusion criteria for participation in the study included
anyone who was at least 18 years of age and had a history
of illicit opioid use (past 30 days or prior to entry into
drug treatment). Participants were recruited in St. Peters-
burg, Russia from June to October 2006 at one of two
study sites. Thirty patients who had entered substance
abuse treatment within the previous six weeks were
recruited at the State Narcological Hospital (SNH). An
additional 30 out-of-treatment opioid users were
recruited at the Biomedical Center (BMC), a private non-
profit biomedical research institution. Participants were
recruited as a convenience sample. The targeted sample
size of 60 was based upon the ability to detect a past-year
opioid overdose prevalence of ≥45% with 80% power and
5% error; it was also considered to be a realistic and feasi-
ble sample size to recruit within the timeframe of this
pilot study. Efforts were made to recruit at times of highest
potential participant availability (i.e., during the daytime
at SNH and evenings at BMC). The study was approved by
the Yale University Human Investigations Committee and
the institutional review boards at the two St. Petersburg
sites. All participants provided informed consent prior to
data collection and were remunerated with gifts equiva-
lent to US$10 for participating.
Study Procedures
Each participant completed a face-to-face interview with a
trained interviewer. Time to complete the survey was
approximately 60–90 minutes. The instrument, specifi-
cally developed for this study, included a series of ques-
tions covering (1) sociodemographic factors, (2)
knowledge about overdose symptoms, risk factors, and
prevention strategies, (3) self-reported history of having
witnessed overdoses and details about the most recently
witnessed overdose, and (4) self-reported history of hav-
ing personally experienced an overdose and details of
their most recent overdose.
Four open-ended questions assessing recall knowledge of
overdose symptoms, risk factors, and prevention strate-
gies appeared at the beginning of the interview and before
asking about overdose experience. These four items typi-
cally elicited short responses (e.g., responses for opioid
overdose symptoms included "cyanosis", "blue lips/face",
"not breathing", "unresponsive"). Each response was
coded for accuracy (accurate/inaccurate) based upon the
current scientific understanding of overdose symptoms,
risk factors, and preventive measures (e.g., not injecting
alone, avoid using alcohol or other central nervous system
depressants in combination with opioids, injecting a
small preliminary dose to judge the strength of the drug).
Responses were independently coded by two researchers
(TCG, KB) for content and accuracy level, and the final
content and accuracy codes were established by consensus
(LEG, TCG, MT, KB).
Prior to asking a series of forced-choice questions about
the history and details of witnessed or self-sustained over-
doses, the following description of overdose symptoms
was provided in order to promote consistency in report-
ing: "There are two different types of overdoses. The symp-
toms are as follows: 1. Amphetamine overdose: the
person is 'going crazy' (psychosis), 'shakes' or seizures,
racing heartbeat, severe sweating or clammy body. 2. Opi-
oid/heroin overdose: pale or blue skin, shallow or infre-
quent breathing, loss of consciousness, insensitivity to
pain, no response to shaking or calling the person's
name."Harm Reduction Journal 2009, 6:17 http://www.harmreductionjournal.com/content/6/1/17
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The final section of the instrument included items from
the Addiction Severity Index (ASI) [14-16] and the Symp-
tom Checklist-90 (SCL-90-R) [17-20]. The ASI and SCL-
90-R are multidimensional, self-report measures that are
frequently used in clinical and research settings to evalu-
ate and monitor potential problems salient to mental
health and substance abuse treatment. The ASI assesses
the perceived severity of problems and need to seek pro-
fessional help for each of seven domains (i.e., medical,
employment, alcohol, drug use, legal, family, and psychi-
atric) such that higher scores signify greater perceived
problems for the given domain. Only those ASI items that
were necessary for generating the seven composite scores
were included in our survey. The SCL-90-R assesses psy-
chological symptoms within nine domains (i.e., somati-
zation, obsessive-compulsive, interpersonal sensitivity,
depression, anxiety, hostility, phobic anxiety, paranoid
ideation, and psychoticism) as well as quantifying a per-
son's overall level of psychological distress (i.e., global
severity index). The Russian version of the SCL-90-R has
not been normed, and clinical cutoff scores do not exist.
However, higher scores are indicative of greater perceived
distress concerning the given domain.
Data Analyses
Data were entered into a Microsoft Access database and
exported to SPSS version 12.0 for analysis. The primary
outcomes were recent (past 12 months) self-sustained
overdose experience and number of recently witnessed
overdoses. Lacking normative scores for the Russian SCL-
90-R, we compared subscale scores within and across indi-
viduals. ASI composite scores were calculated for five of
the seven domains. The medical and alcohol composites
could not be calculated due to a data collection error in
which two items that are necessary for computing com-
posite scores were inadvertently omitted from the Russian
instrument; for these two subscales, item level analyses
were conducted instead.
Descriptive statistics were calculated to characterize the
study sample. Bivariate analyses to identify possible asso-
ciations of demographic, psychosocial, and contextual
factors with the two outcome variables were performed.
All associations with alpha ≤ 0.1 are reported.
Exploratory regression analyses were conducted to exam-
ine the association between independent variables and
the outcomes of recent self-sustained overdose and the
number of recently witnessed overdoses. Due to the high
prevalence of recent self-sustained overdose, we used the
relative risk regression approach to avoid overestimation
of associations that may occur when the rare disease
assumption needed for logistic regression is not satisfied
[21]. Since witnesses of more and recent overdoses may
have the most impact on reducing overdose rates, we
modeled counts of recently witnessed overdoses (past 12
months) to help elucidate characteristics of a target popu-
lation for future overdose prevention training interven-
tions. Thus, a negative binomial regression of the number
of recently witnessed overdoses was estimated. Correlates
of the overdose outcomes were those with significant
association (p ≤ 0.10) in the bivariate analyses, and we
also controlled for potential confounders (e.g., site). The
model building proceeded using backward and forward
approaches in a non-automated fashion. Parsimony
guided the final model decision in the interest of conserv-
ing statistical power.
Results
Sample Characteristics
The study sample (n = 60) consisted primarily of young,
male, injection drug users (Table 1). The majority of par-
ticipants resided with partners or parents, with only
21.7% living alone. More than half of the sample had uni-
versity or specialized professional schooling (55.0%), but
only 26.7% were currently employed. Geographic distri-
bution of residence was fairly even across the four quad-
rants of the city, and few (< 7%) resided beyond the city
limits.
Relative to the other ASI subscales, the employment, psy-
chiatric, and family composite scores were the highest. ASI
item-level findings revealed that medical problems were
common, with an average of 10 days of medical problems
reported in the previous 30. By contrast, alcohol use and
problems related to alcohol were reported infrequently.
The SCL-90 scores were lowest for the psychoticism sub-
scale and highest for the obsessive-compulsive and inter-
personal sensitivity subscales.
Half the sample was recruited from a hospital-based treat-
ment site (SNH), and consequently only five of these par-
ticipants (16.7%) had injected drugs in the past month
(all Russian drug treatment is abstinence-based); all had
injected within the past six weeks, however. All partici-
pants not in hospital-based treatment (BMC) reported
injecting heroin in the past 30 days. Almost three quarters
of the sample reported injecting heroin at their most
recent injection (74.6%) or injecting with others all or
most of the time (70.7%).
There were several differences in the sample according to
recruitment site. The SNH sample was younger (26.7 years
vs. 35.0 years, p < 0.001), initiated opioid use at a younger
age (17.7 years vs. 22.7 years, p < 0.001), and experienced
their first opioid overdose at a younger age (21.2 years vs.
27.5 years, p < 0.005) than the BMC sample. SNH partic-
ipants were less likely to have witnessed an overdose
within the previous year (53.3% vs. 79.3%, p < 0.05) but
were more likely to report having been present when theHarm Reduction Journal 2009, 6:17 http://www.harmreductionjournal.com/content/6/1/17
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Table 1: Study population socio-demographics and overdose experience
Variable N (%) Mean (SD)
Site
State Narcological Hospital 30 (50)
Biomedical Center 30 (50)
Age in years [mean (SD)] 30.8 (7.5)
Male 37 (61.7)
Age at first opioid use [mean (SD)] 20.3 (5.8)
Years from first opioid use to first opioid overdose [mean (SD)] 4.5 (6.0)
Living situation
Alone 13 (21.7)
Parents 26 (43.3)
Spouse 13 (21.7)
Sex partner 2 (3.3)
Relatives 5 (8.3)
With friends 1 (1.7)
Highest level of education
Did not complete middle school 11 (18.3)
Completed middle school 16 (26.7)
Special middle (PTU/tech school) 18 (30.0)
Institute//university 15 (25.0)
Currently employed 16 (26.7)
District of inhabitance
Central 12 (20.3)
South 15 (25.4)
North 17 (28.8)
East 11 (18.6)
Suburbs 6 (6.8)
Addiction Severity Index
Legal composite 0.13 (0.17)
Family composite 0.38 (0.21)
Psychiatric composite 0.39 (0.24)
Drug composite 0.14 (0.10)
Employment composite 0.75 (0.26)
Medical, items:
Days bothered by medical problems* 10.53 (10.35)
How troubled by medical problems** 2.13 (1.29)
Alcohol, items:
Days used alcohol* 4.61 (7.71)
Days used alcohol to intoxication* 1.71 (3.48)
Days experiencing problems with alcohol* 3.10 (7.22)
How troubled by alcohol problems** 0.77 (1.17)
Importance of getting treatment for alcohol problems** 0.97 (1.46)Harm Reduction Journal 2009, 6:17 http://www.harmreductionjournal.com/content/6/1/17
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overdose victim died or woke up (82.1% vs. 10.3%, p <
0.0001). Study site differences were controlled for in the
subsequent regression analyses.
Overdose Knowledge and Attitudes
Participants accurately described opioid overdose symp-
toms, with 86.7% of the sample mentioning one or more
actual symptoms; most frequently mentioned were cyano-
sis (56.7%), loss of consciousness (53.5%), and absence
of breathing (51.7%). In contrast, only 21.7% of respond-
ents provided correct amphetamine overdose symptoms;
46.7% of respondents reported not knowing any symp-
toms. Participants correctly identified key risk factors for
opioid overdose such as taking too large a dose (24.4%),
mixing drugs with alcohol (21.1%), and variability of
drug quality (17.8%). However, misinformation about
overdose risk factors was observed; "bad self-control" or a
flawed character was mentioned by approximately one in
five individuals. Effective overdose prevention strategies
identified by participants included a preliminary injection
or "tasting" of a small quantity of drug (38.3%) and not
mixing drugs and alcohol (13.3%). Less effective or inef-
fective strategies were also reported: knowing one's opti-
mal dose (31.7%) and judging the physical appearance of
the drug (3.3%). Eight participants (13.3%) failed to
mention any strategy. Abstinence (6.7%) and better self-
control (3.3%) were also noted as effective, albeit nonspe-
cific, strategies for reducing overdose risk.
Nearly half of participants (41.4%) reported lacking con-
fidence in or being unsure of their ability to help in an
overdose situation. They expressed interest in receiving
information about overdose prevention (76.3%) or train-
ing on how to respond to an opioid overdose (67.2%).
Less than half of the sample (44.1%) had heard of
naloxone despite its availability by prescription at phar-
macies in Russia and its use in hospitals and some emer-
gency response service units.
Reports of Overdoses in the Community
Reports of overdoses, both fatal and nonfatal, were com-
mon. Participants reported having heard of a median of
five (range = 0 – 60) non-fatal overdoses and of two
(range = 0 – 30) fatal overdoses in the past year alone.
Almost two thirds of participants (63.3%) reported that
all or most of their friends had ever overdosed. Fifteen
respondents (25.0%) rated their risk of personally over-
dosing as somewhat or extremely likely during the next
year, and a similar proportion were somewhat or
extremely concerned about this risk (28.3%). Participants
were more concerned about their peers' potential risk for
overdose than their own (50% vs. 28.3%).
Self-sustained Overdose Experience
Three quarters of participants had personally experienced
an opioid overdose in their lifetime, and the median life-
time number of overdoses was 4 (25, 75 percentile: 2, 10).
The median age at first overdose was 21.5 years (25th, 75th
percentile: 19, 27), and the mean time from first opioid
use to first overdose was 4.5 years (SD 6.0). Most partici-
pants who reported having ever overdosed had experi-
enced at least one within the previous year (60.0%, or
45.0% of total sample). Eight participants (17.8%) had
ever been hospitalized following their overdose, usually
only once (62.5%) (Figure 1).
SCL-90 Mean score (SD)
Global Severity Index 1.24 (0.69)
Obsessive-compulsive 1.79 (1.09)
Interpersonal sensitivity 1.45 (0.87)
Depression 1.25 (0.94)
Anxiety 1.35 (0.95)
Hostility 1.39 (0.94)
Phobic anxiety 0.82 (0.85)
Paranoid ideation 1.13 (0.88)
Psychoticism 0.70 (0.76)
Somatization 1.31 (0.82)
Ever injected 59 (98.3)
Past 30 days, injected 29 (49.2)
Heroin 29 (100)
Opioids 4 (13.8)
Amphetamines 2 (6.9)
Other 3 (10.3)
Inject alone all or most of the time 17 (29.3)
*in the past 30 days
**(0 = not at all 4 = extremely)
Table 1: Study population socio-demographics and overdose experience (Continued)Harm Reduction Journal 2009, 6:17 http://www.harmreductionjournal.com/content/6/1/17
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Heroin was the most commonly reported drug used at last
overdose (95.6%), with alcohol (11.1%) or other opioids
(8.9%) reported less frequently. Immediately prior to
their last overdose, some participants had been in drug
treatment (24.4%) or incarcerated (18.2%). Most over-
doses occurred at home (42.2%), at a friend's home
(17.8%), or on the street (20.0%). Others were usually
present (77.8%) at participants' last overdose and
attempted resuscitation procedures over half (60.0%) the
time. No resuscitation was attempted in 8.9% of cases in
which others were present. The most commonly reported
resuscitation procedure was physical stimulation (36.5%)
such as slapping, walking around, applying cold water or
ice. Medical intervention (e.g., CPR/rescue breathing or
administering naloxone) was reported in 33.3% of cases.
Less effective resuscitation activities (e.g., saline or milk
injection) were performed in 6.3% of cases. Of those who
recalled what happened to them at their last overdose, five
people reported receiving medical attention (11.1%), and
two were taken to the hospital for a one-day stay. Police
did not arrive at any of the last reported self-sustained
overdoses.
Factors Associated with Recent Self-Sustained Overdose
Recent overdose was defined as one that occurred in the
past year. Correlates of recent overdose (Table 2) included
a greater number of lifetime previous overdoses (median
of 5), a higher SCL-90 subscale score for somatization,
stronger expectations of personally experiencing another
overdose, and higher ASI family composite scores, reflect-
ing greater perceived problematic family interactions.
Examination of family subscale items revealed that people
reporting problematic interactions with their mothers – as
opposed to other family members – were at risk of experi-
encing a recent overdose. They were also more troubled by
their family problems and felt it more important to seek
help for these family problems than did participants who
had not experienced a recent overdose. An exploratory rel-
ative risk regression revealed two independent correlates
of having a recent self-sustained overdose: having previ-
ously overdosed and higher scores on the somatization
subscale (Table 2).
Witnessing overdoses
All but one participant had ever witnessed an overdose
(98.3%), and two thirds (66.1%) had witnessed at least
one within the previous year (median 2; 25, 75 percentile:
1, 4; Figure 2). Altogether, participants reported witness-
ing a total of 226 overdoses in the past year. In only 20.8%
of these instances was an ambulance called. The most
commonly reported reasons for not calling an ambulance
were: confidence in ability to resuscitate without medical
intervention (54%), fear of police (14.3%), and lack of
confidence in the ambulance response (11.4%).
When asked about the last witnessed overdose, regardless
of its recency, most participants had been present when
the overdose victim had taken drugs (82.8%), when the
person became distressed (86.2%), and when the person
became unconscious (96.6%). By contrast, fewer partici-
pants reported being present at the time of medical
response or ambulance arrival (49.2%) or at the end when
Prevalence, recency and disposition of self-sustained overdoses in a sample of 60 opioid abusers in St. Petersburg, Russia Figure 1
Prevalence, recency and disposition of self-sustained overdoses in a sample of 60 opioid abusers in St. Peters-
burg, Russia.
Sample Size: 60
Ever Overdosed: 45 (75%) Never Overdosed: 15 (25%)
Recency of Overdose
< 1 year: 27 (60%)
> 1 year: 18 (40%)
Not hospitalized: 37 (82%)
Disposition
Hospitalized: 8 (18%)
One time only: 5 (63%)
> 1 time: 3 (38%)Harm Reduction Journal 2009, 6:17 http://www.harmreductionjournal.com/content/6/1/17
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the person died or was revived (45.6%), suggesting that
leaving an overdose scene is common. The overdose vic-
tim died in five (8.6%) of the last witnessed overdoses
(Figure 2). All victims had used heroin, primarily by injec-
tion (91.5%); 59.3% had also used alcohol; 8.5% had
also used amphetamines; and three cases had reportedly
ingested some other substance in addition to heroin. The
overdoses tended to occur in private settings, primarily at
home (30.5%) or at a friend's home (25.4%), but many
occurred in public places (25.4%). The most commonly
perceived causes of the last witnessed overdose were com-
bined drug and alcohol use (32.2%), purity of the drug
(28.8%), a recent period of abstinence (11.9%), or recent
release from either drug treatment or incarceration
(8.5%).
It was the norm that multiple persons witnessed over-
doses. On average, 3.2 people (SD 3.1, median = 2) were
present at the last witnessed overdose. In most instances
(86.4%), witnesses were drug users. Fellow drug users
were also listed most often (79.7%) as a resuscitator at the
last witnessed overdose. Hospital (10.2%) and ambu-
lance (6.8%) staff were also mentioned as resuscitators.
Multiple resuscitation strategies were typically employed.
The most commonly reported strategies attempted during
the last witnessed overdose were physical stimulation
(67.8%) and CPR/rescue breathing (57.7%). Participants
reported that an ambulance was called in 37.3% of the
last witnessed overdoses and arrived in a median of 20
minutes (range 5 – 60). Naloxone was administered in
five cases (22.7%), two of which did not involve a request
for an ambulance.
Variables associated with having witnessed more over-
doses in the past year were being more concerned about
personal and others' risk of overdose, higher expectation
of future self-sustained overdose, more reported days with
medical problems in the past month, being more troubled
by medical problems, and higher scores on the SCL-90-R
somatization subscale and ASI family and drug composite
scores. In the negative binomial regression (controlling
for site), having higher expectations of future self-sus-
tained overdose and being more troubled by medical
problems in the past month were associated with having
witnessed a greater number of recent overdoses (Table 3).
Discussion
Our study is the only one to date that examines opioid
overdose risk among St. Petersburg drug users and the first
to explore the relationship between opioid overdose expe-
rience and psychological screening measures that are used
in Russian clinical settings. Most overdoses involved her-
oin and occurred in private residential settings. Similar to
other regional studies conducted in Central and Eastern
Europe and the former Soviet Union [9,10], we found that
witnessing or personally experiencing an opioid overdose
was very common. In contrast to other overdose studies in
Australia, Great Britain, and the United States [22-26], a
higher proportion of our participants had experienced at
least one overdose within the previous year, and the life-
time number of overdoses was substantially greater.
Table 2: Variables Associated With recent experience of an opioid overdoses
Bivariate Analyses Relative Risk Regression
Adjusted Risk Ratio 95% Confidence Interval
Previously overdosed χ2 = 14.6 *** 1.7 1.1 – 2.6
Number of overdoses experienced U = 142.50***Z = -4.33
Perceived Likelihood of overdosing again χ2 = 5.72*
Higher SCL-90 Somatization score t58 = 2.50** 1.2 0.96 – 1.5
Higher ASI Family composite score t56 = 2.49*
Problems with mother χ2 = 4.42*
Troubled by family problems t57 = 2.26*
Importance of getting help for family problems t57 = 2.50*
* p < 0.05
** p < 0.01
*** p < 0.001Harm Reduction Journal 2009, 6:17 http://www.harmreductionjournal.com/content/6/1/17
Page 8 of 11
(page number not for citation purposes)
Larger scale studies of drug users in St. Petersburg are
needed to confirm if these observations are generalizable.
Our findings also indicated that participants were quite
knowledgeable about opioid overdose symptoms. How-
ever, misinformation and gaps in knowledge exist. For
example, "knowing one's optimal dose" was cited by
almost one quarter of the sample as an effective overdose
prevention strategy. Overdose prevention programs
should inform drug users that this strategy is impossible
in practice when using heroin since drug strength can vary
substantially. The study findings also indicated that St.
Petersburg drug users tended to overdose within four
years of initiating opioid use. This suggests the impor-
tance of reaching individuals early in their drug use
careers and educating them about overdose risk, recogni-
tion, and prevention. Participants were less knowledgea-
ble about stimulant overdose than about opioid overdose.
This observation, coupled with the reported increases in
cocaine and stimulant use in Russia [27], suggests the
need for studies on the prevalence of stimulant overdose,
its prevention, and the development of effective commu-
nity-based response interventions. Furthermore, requests
for an ambulance were infrequent. It is hypothesized that
this observation may be a function of drug users' skepti-
cism about the effectiveness of the emergency response
system and concerns about potential police involvement
[28].
The strongest correlates of experiencing a recent overdose
were previous self-sustained overdose experience fol-
lowed by a higher SCL-90-R somatization subscale score.
One hypothesis to account for the first finding is that peo-
ple tended to continue to engage in behaviors that
increased their risk of overdose (e.g., combined use of opi-
oids and alcohol). The finding concerning the SCL-90-R
somatization subscale suggests that suboptimal health
status may place individuals at risk of overdose. The
somatization subscale assesses the perceived level of phys-
ical distress (e.g., headache, pains, numbness) such that a
person suffering from physical problems will score higher
than someone with little or no physical complaints. Since
we did not collect health status data, it is possible that the
subscale may have served as an indirect measure of under-
lying illness. Infections such as HIV or hepatitis C, both of
which are endemic among Russian injectors [29,30],
Prevalence, recency and reported outcomes of witnessed overdoses in a sample of 60 opioid abusers in St. Petersburg, Russia Figure 2
Prevalence, recency and reported outcomes of witnessed overdoses in a sample of 60 opioid abusers in St. 
Petersburg, Russia.
Sample Size: 60
Ever Witnessed an Overdose: 59 (98%) Never Witnessed an Overdose: 1 (2%)
Recency of Last Witnessed Overdose
< 1 year: 39 (66%)
> 1 year: 20 (34%)
Fatal: 5 (9%)
Outcome of Last Witnessed Overdose Non-fatal: 52 (88%)
Not reported: 2 (3%)Harm Reduction Journal 2009, 6:17 http://www.harmreductionjournal.com/content/6/1/17
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interfere with optimal immune functioning and metabo-
lism and place individuals at increased risk of drug over-
dose [31].
Greater perceived likelihood of overdosing in the future
and concerns about personal medical problems were the
strongest correlates of witnessing more overdoses
recently. One hypothesis to account for the association
between perceived likelihood of future overdose and wit-
nessing multiple overdoses recently is that the act of wit-
nessing may heighten one's awareness of the
pervasiveness of overdose and sense of fatalism about the
future. In addition, drug users who have recently wit-
nessed multiple overdoses may be ideal candidates for an
overdose prevention intervention and may have a strong
impact on reducing overdose rates within their commu-
nity. Additional research is needed to clarify these issues.
Several limitations in this study should be noted. First, the
potential generalizability of the findings is limited by the
study's non-random sampling strategy. Although we sam-
pled at two different venues, drug users not seeking treat-
ment or unwilling to participate in research studies may
be under-represented. Second, given the relatively small
sample size and limited power, regression analyses should
be interpreted with caution and viewed as exploratory in
nature. We attempted to limit the number of variables
included in the regressions to those permissible for our
sample size, but relationships should optimally be tested
with a larger, more representative sample. The cross-sec-
tional nature of this study does not permit determination
of causal associations. Finally, only self-reported data
were collected and therefore are open to the vulnerabili-
ties of social desirability bias, interviewer bias, and recall
bias. We made every effort to be empathic and non-judg-
mental and to provide specific definitions for opioid over-
dose and stimulant overdose in order to reduce
measurement error in reporting. Nevertheless, it is possi-
ble that biases may have influenced our findings.
Conclusion
The observation that virtually all respondents had opioid
overdose experience (both direct and indirect) speaks to
the magnitude of the problem in St. Petersburg. Expecta-
tions about respondents' and their drug-using friends'
strong likelihood of overdosing in the future provide evi-
dence of their awareness of and concern about overdose
risk. Drug users noted their lack of confidence in being
able to respond to overdose situations and were interested
in receiving training on overdose prevention, recognition,
and response. This study highlights the need for and
potential receptiveness to an overdose prevention pro-
gram. The results also suggest that the involvement of
family members in drug treatment and overdose preven-
Table 3: Variables associated with recent witnessing of an opioid overdoses
Number of Witnessed Overdoses 
(past year)
Negative Binomial Regression
Adjusted Parameter Estimate 95% Confidence Interval
Greater perceived likelihood of 
overdosing again
ρs = .43*** 0.3 0.02 – .50
Greater concern for self-sustained 
overdose risk
ρs = .33**
Greater concern for others' overdose risk ρs = .32**
Higher SCL-90 Somatization score ρs = .40***
Higher ASI Drug composite score ρs = .37**
Higher ASI Family composite score ρs = .31* 0.7 -0.9 – 2.4
More days with medical problemsa ρs = .32**
More troubled by medical problemsa ρs = .42*** 0.6 0.3 – 0.8
* p < 0.05
** p < 0.01
*** p < 0.001
a Past 30 days
ρs = Spearman correlation coefficientHarm Reduction Journal 2009, 6:17 http://www.harmreductionjournal.com/content/6/1/17
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tion programs may also be effective in reducing opioid-
related harms.
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